Premarket Mover: Phio Pharmaceuticals Corp (PHIO) Down 12.67%

Phio Pharmaceuticals Corp (PHIO) has fallen Friday morning, with the stock falling -12.67% in pre-market trading to 4.41. PHIO's short-term technical score of 49 indicates that the stock has traded less bullishly over the last month than 51% of stocks on the market. In the Biotechnology industry, which ranks 87 out of 146 industries, the stock ranks higher than 56% of stocks. Phio Pharmaceuticals Corp has risen 2.85% over the past month, closing at $3.85 on April 21. During this period of time, the stock fell as low as $3.23 and as high as $4.92. PHIO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

PHIO has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on PHIO!

See Full PHIO Report

Phio Pharmaceuticals Corp has a Long-Term Technical rank of 66. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 34% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, PHIO ranks better than 89% of stocks.

Important Dates for Investors in PHIO:

-Phio Pharmaceuticals Corp is set to release earnings on 8/9/2023. Over the last 12 months, the company has reported EPS of $-3.15. -We do not have a set dividend date for Phio Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Phio Pharmaceuticals Corp (PHIO)